James Lupski has been named a fellow of the American Academy of Arts and Sciences.
Lupski holds the Cullen Endowed Chair in Molecular Genetics at Baylor College of Medicine, where he is also vice chair and professor of molecular and human genetics. He has discovered several disease genes, including the first gene for Charcot-Marie Tooth syndrome as well as the gene for the form of the disorder that affects him through next-generation sequencing. He holds a BS and PhD from New York University and an MD from New York University Medical School.
The National Institutes of Health appointed 10 individuals to the NIH Council of Councils, which advises the NIH Director on policies and activities of the Division of Program Coordination, Planning, and Strategic Initiatives. Among those appointed was Carlos Bustamante, a professor of genetics at Stanford University and co-founding director of the Stanford Center for Computational, Human, and Evolutionary Genomics.
Bioinformatics firm Golden Helix has hired Andreas Scherer to be its new president and CEO. Scherer has managed large global software services businesses, and he started his executive career at AOL/Netscape. He will replace Former CEO Christophe Lambert, who will take on the new role of company chairman.
Transgenomic's chief commercial officer Chad Richards resigned, effective May 10, the company said in a filing with the US Securities and Exchange Commission this week. Transgenomic said it has not named a replacement.